13
Views
17
CrossRef citations to date
0
Altmetric
Research Article

THE HEMOLYTIC PLAQUE-FORMING CELL ASSAY IN TILAPIA (OREOCHROMIS NILOTICUS) EXPOSED TO BENZO[a]PYRENE: ENHANCED OR DEPRESSED PLAQUE FORMATION DEPENDS ON DOSING SCHEDULE

Pages 57-70 | Published online: 30 Sep 2008
 

Abstract

The prospect of utilizing the cichlid teleost tilapia (Oreochromis niloticus) as an alternative experimental model to mammals for preliminary chemical immunotoxicity risk assessment is being evaluated by examining the National Toxicology Program's standard battery of rodent immunotoxicity assays in chemicaltreated tilapia. The present report examines the hemolytic plaque forming cell assay (PFC), a quantitative indicator of antibody production, in tilapia exposed to the polycyclic aromatic hydrocarbon (PAH) benzo[a]pyrene (B[a]P). Reduced antibody production against sheep red blood cell (SRBC) antigen in response to B\[a]P was observed using the PFC assay, via reduction in plaque number. Under specific immunization circumstances, increased plaque formation was observed in chemical-exposed fish, an effect also reported in rodents. Although the normal teleost immune responsiveness was weaker than seen with mice under comparable conditions (presumably due to differences in antibody structure of teleosts), tilapia werefound toexhibit well-defined primary and secondary humoral responses to SRBC, and an immunotoxic response to B[a]P comparable to the rodent model.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.